Top Markets
Coin of the day
Creso Pharma Limited Creso Pharma Limited

Creso Pharma Limited

CPH
Classement en actions #30562
Creso Pharma Ltd. specializes in the development, registration, and... Creso Pharma Ltd. specializes in the development, registration, and commercialization of high-quality, pharmaceutical-grade cannabis and hemp-derived nutraceuticals. These health solutions are designed for both human and animal wellness, distributed across Europe, the Middle East, North America, and the Asia Pacific. The company also undertakes the creation and sale of therapeutic products, in addition to cultivating, processing, and supplying cannabis products to retail markets. Among its diverse product line are "anibidiol," a complementary feed for companion animals; "cannaQIX," a nutraceutical containing hemp oil extract, vitamins, and zinc, formulated to reduce stress and support psychological and nervous system functions; and topical skincare items like "cannaDOL," a CBD-based gel featuring a blend of cooling and warming essential oils. Creso Pharma Limited was founded in 2015 and operates from its headquarters in Nedlands, Australia.
Prix de l'action
$0.00634756
Dernière synchronisation: 2023-06-09
Capitalisation boursière
$16.30M
Changement (1 jour)
5.01%
Changement (1 an)
0.00%
Pays
AU
Échange Creso Pharma Limited (CPH)

Catégorie

Bénéfices pour Creso Pharma Limited (CPH)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Creso Pharma Limited, les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Creso Pharma Limited de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes